Stay updated on Simufilam 100 mg in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.

Latest updates to the Simufilam 100 mg in Alzheimer's Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check14 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new version of the study on simufilam for Alzheimer's disease, including the addition of collaborators and a revision number. Key details about the study's design, including patient enrollment and treatment protocols, have been retained, but some specific objectives and descriptions have been removed.SummaryDifference26%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to Simufilam 100 mg in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.